Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Isaacs

Showing results (31-40 of 160) with videos related to

Pageof 16
Sort By:
Inflammatory Bowel Diseases|January 15, 2013
Rifaximin in IBD: is it time to beat back the bugs as induction therapy in Crohn's disease?Kim L Isaacs
Integrative Medicine (Encinitas, Calif.)|April 9, 2026
Unconventional Medicine and Institutional Resistance: A Case History About the Uphill Battles Facing an Innovative Cancer TherapyLinda L Isaacs
Health Affairs (Project Hope)|January 1, 1996
Consumer's information needs: results of a national surveyS L Isaacs
Integrative Cancer Therapies|July 31, 2024
Hypothesis: Proteolytic Proenzymes Have a Role in the Ornish Program for Prostate CancerLinda L Isaacs
Pediatrics|April 1, 1973
The law and the abused and neglected childJ L Isaacs
The American Journal of Pathology|June 1, 1983
Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexesK L Isaacs, F Miller
The Journal of Legal Medicine|December 1, 1987
Drug regulation, product liability, and the contraceptive crunch. Choices are dwindlingS L Isaacs, R Holt
Journal of Clinical Gastroenterology|April 1, 1990
Pancreatitis after rectal administration of 5-aminosalicylic acidK L Isaacs, D Murphy
Inflammatory Bowel Diseases|November 24, 2015
Navigating the Affordable Care Act and the Patient with Inflammatory Bowel DiseaseKim L Isaacs, Shifali Arora
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1982
Role of antigen size and charge in immune complex glomerulonephritisK L Isaacs, F Miller
Pageof 16

Showing results (31-40 of 160) with videos related to

Sort By:
Pageof 16
Inflammatory Bowel Diseases|January 15, 2013
Rifaximin in IBD: is it time to beat back the bugs as induction therapy in Crohn's disease?Kim L Isaacs
Integrative Medicine (Encinitas, Calif.)|April 9, 2026
Unconventional Medicine and Institutional Resistance: A Case History About the Uphill Battles Facing an Innovative Cancer TherapyLinda L Isaacs
Health Affairs (Project Hope)|January 1, 1996
Consumer's information needs: results of a national surveyS L Isaacs
Integrative Cancer Therapies|July 31, 2024
Hypothesis: Proteolytic Proenzymes Have a Role in the Ornish Program for Prostate CancerLinda L Isaacs
Pediatrics|April 1, 1973
The law and the abused and neglected childJ L Isaacs
The American Journal of Pathology|June 1, 1983
Antigen size and charge in immune complex glomerulonephritis. II. Passive induction of immune deposits with dextran-anti-dextran immune complexesK L Isaacs, F Miller
The Journal of Legal Medicine|December 1, 1987
Drug regulation, product liability, and the contraceptive crunch. Choices are dwindlingS L Isaacs, R Holt
Journal of Clinical Gastroenterology|April 1, 1990
Pancreatitis after rectal administration of 5-aminosalicylic acidK L Isaacs, D Murphy
Inflammatory Bowel Diseases|November 24, 2015
Navigating the Affordable Care Act and the Patient with Inflammatory Bowel DiseaseKim L Isaacs, Shifali Arora
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1982
Role of antigen size and charge in immune complex glomerulonephritisK L Isaacs, F Miller
Pageof 16